., Abida
-
Vol 11, No 4 (2024): Advancements in Life Sciences - Review Articles
Mavorixafor: A spotlight on the clinical aspects and prospects of the first USFDA-approved treatment for the primary immunodeficiency WHIM syndrome
Abstract PDF
ISSN: 2310-5380